ARTICLE | Finance
Solasia goes to market
Solasia becomes Japan’s first public biotech in months and looks to China
March 25, 2017 12:43 AM UTC
After becoming the first Japanese biotech to go public in 18 months, Solasia Pharma K.K. (Tokyo:4597) plans to use the proceeds to prepare to launch its first products in China.
Solasia raised ¥3.6 billion ($32 million) through the sale of 19.4 million shares at ¥185 in an IPO on Tokyo Stock Exchange's Mothers on Friday for a postmoney valuation of ¥15.5 billion ($138.4 million)...
BCIQ Company Profiles